US FDA Approves New Indication For CRESTOR® (Rosuvastatin Calcium)
Links shared publicly online about this topic.
- 1,392total visits
US FDA Approves New Indication For CRESTOR® (Rosuvastatin Calcium)
View full resource at medicalnewstoday.com
Tags: Cholesterol Medication, Mineral, Calcium, Drug, Supplement, FDA, Crestor, AstraZeneca
Most Recently Shared on February 10, 2010 at 7:13 pm By:
US FDA Approves New Indication For CRESTOR® (Rosuvastatin Calcium) http://mnt.to/3xrb #clinicaltrials
Also Shared By:
Bayer HealthCare receives FDA approval for Natazia to treat HMB
news-medical.net — “Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.” View full resource at news-medical.net
Most Recently Shared on March 15, 2012 at 4:43 am By:
Bayer HealthCare receives FDA approval for Natazia to treat HMB: Bayer HealthCare Pharmaceuticals Inc. today ann... http://t.co/owLKhz1u
Baxter U.S. - Baxter Announces FDA Approval of ARTISS Fibrin Sealant For Use in Face-Lift (Facial Rhytidectomy) Procedures
baxter.com — “Baxter Announces FDA Approval of ARTISS Fibrin Sealant For Use in Face-Lift (Facial Rhytidectomy) Procedures” View full resource at baxter.com
Most Recently Shared on September 6, 2011 at 2:30 pm By:
Baxter announces FDA approval of new indication for ARTISS http://t.co/l3P63Q0
U.S. Food and Drug Administration Approves Gilead Sciences' Complera, a New Complete Once-Daily, Single-Tablet Regimen for HIV-1 Infection in Treatment-Naïve Adults
drugs.com — “Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) is used to treat HIV infection. Includes Complera side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 10, 2011 at 11:27 pm By:
FDA Approves Complera, a Once-Daily, Single-Tablet Regimen for HIV-1 Infection - http://bit.ly/nXmNLg
Watson seeks FDA approval to market generic version of Pfizer's Viagra
news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Sildenafil Citrate Tablets, 25, 50 and 100 mg. Watson's Sildenafil Citrate tablets are a generic version of Pfizer Inc.'s Viagra®, which is indicated for the treatment of erectile dysfunction (ED).” View full resource at news-medical.net
Most Recently Shared on June 3, 2011 at 12:47 pm By:
Watson seeks FDA approval to market generic version of Pfizer's Viagra: Watson Pharmaceuticals, Inc. today confi... http://bit.ly/jEYgoE
FDA Approves New HIV Treatment Edurant (rilpivirine)
drugs.com — “Edurant (rilpivirine) is used to treat HIV-1 infection. Includes Edurant side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 21, 2011 at 1:04 am By:
FDA Approves New HIV Treatment Edurant (rilpivirine): May 20, 2011 -- The U.S. Food and Drug Administratio... http://bit.ly/lP7KHQ #drug
FDA approves expanded access to RX Acculink stent for clogged neck artery treatment
news-medical.net — “The U.S. Food and Drug Administration today approved an expanded indication that will allow a new group of patients at risk of stroke due to clogged neck arteries to be treated with the RX Acculink carotid stent.” View full resource at news-medical.net
Most Recently Shared on May 7, 2011 at 9:39 am By:
FDA approves expanded access to RX Acculink stent for clogged neck artery treatment: The U.S. Food and Drug Admi... http://bit.ly/lulxVT
FDA Expands Approved Use For Carotid Stent
medicalnewstoday.com — “The U.S. Food and Drug Administration today approved an expanded indication that will allow a new group of patients at risk of stroke due to clogged neck arteries to be treated with the RX Acculin” View full resource at medicalnewstoday.com
Most Recently Shared on May 6, 2011 at 5:05 pm By:
FDA Expands Approved Use For Carotid Stent http://mnt.to/3Vxj #regulatory
UCSF scientists play key role in success of Yervoy, a new cancer drug
medicalxpress.com — “Yervoy is unlikely to win a contest for best named drug, but recent US Food and Drug Administration (FDA) approval for the new entrant in the battle against cancer marks the success of a novel treatment strategy, and is another indicator that immunotherapy has gone mainstream.” View full resource at medicalxpress.com
Most Recently Shared on May 6, 2011 at 1:52 pm By:
UCSF scientists play key role in success of Yervoy, a new cancer drug http://tw.medicalxpress.com/223894307
FDA considers new rules to speed up confirmatory trials of drugs granted accelerated approval
physorg.com — “Since 1992, the U.S. Food and Drug Administration has granted accelerated approval to 47 new indications for 35 cancer drugs and in more than half the cases26 indicationsfurther trials have confirmed the benefits of the drugs. But the agency has concerns about the length of time some drugs ...” View full resource at physorg.com
Most Recently Shared on March 25, 2011 at 9:23 pm By:
FDA considers new rules to speed up confirmatory trials of drugs granted accelerated approval http://tw.physorg.com/220292446
FDA Considers New Rules To Speed Up Confirmatory Trials Of Cancer Drugs Granted Accelerated Approval
medicalnewstoday.com — “Since 1992, the U.S. Food and Drug Administration has granted accelerated approval to 47 new indications for 35 cancer drugs and in more than half the cases - 26 indications - further trials have” View full resource at medicalnewstoday.com
Most Recently Shared on March 25, 2011 at 8:05 pm By:
FDA Considers New Rules To Speed Up Confirmatory Trials Of Cancer Drugs Granted Accelerated Approval http://mnt.to/3SHM #cancer
New HPV Vaccine Indication, February 23, 2011, Kuehn 305 (8): 770 --" JAMA
jama.ama-assn.org — “New HPV Vaccine Indication, February 23, 2011, Kuehn 305 (8): 770 --" JAMA” View full resource at jama.ama-assn.org
Most Recently Shared on February 23, 2011 at 2:19 am By:
New HPV Vaccine Indication [Health Agencies Update]: The US Food and Drug Administration (FDA) has approved the ... http://bit.ly/eWhyXf
Hi-Tech Pharmacal Receives Final Approval For Levofloxacin Ophthalmic Solution - QualityPoint Technologies
qualitypointtech.net — “Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK), a specialty pharmaceuticals company, announced that the US Food and Drug Administration, (FDA) granted final approval for the Company's Abbreviated New Drug Application, (ANDA) for levofloxacin ophthalmic solution, 0.5% the generic for Vistakon's Quixin® ophthalmic solution, which had sales of $2 million for the 12 months ended December 2010 according to IMS sales data. The product is indicated for bacterial conjunctivitis. The Company is preparing ” View full resource at qualitypointtech.net
Most Recently Shared on February 13, 2011 at 11:35 am By:
Hi-Tech Pharmacal Receives Final Approval For Levofloxacin Ophthalmic Solution: Hi-Tech Pharmacal Co., Inc. (NASDA... http://bit.ly/edWqEF
FDA Approves New Dosage Strength For INTELENCE(R)
medicalnewstoday.com — “The U.S. Food and Drug Administration(FDA) approved a label update to include a 200 mg formulation of INTELENCE® (etravirine), a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicate” View full resource at medicalnewstoday.com
Most Recently Shared on January 4, 2011 at 5:05 pm By:
FDA Approves New Dosage Strength For INTELENCE(R) http://mnt.to/3PBF #regulatory
FDA Approves New Dosage Strength for Intelence
drugs.com — “Intelence (etravirine) is used to treat HIV infection. Includes Intelence side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on January 4, 2011 at 4:10 am By:
FDA Approves New Dosage Strength for Intelence: TITUSVILLE, N.J., Jan. 3, 2011 /PRNewswire/ -- The U.S. Fo... http://bit.ly/fCWTaJ #drug
US FDA Approves New Indication for Merck's HPV Vaccine, GARDASIL® | Business Wire
businesswire.com — “Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL®” View full resource at businesswire.com
Most Recently Shared on December 22, 2010 at 10:33 pm By:
US FDA Approves New Indication for Merck's HPV Vaccine, GARDASIL®: WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Me... http://bit.ly/eqNp7F
Advertisement



medical_tweets
@medical_tweets
US FDA Approves New Indication For CRESTOR® (rosuvastatin Calcium) AstraZeneca (NYSE: AZN) announced that the US Foo.. http://bit.ly/a4TRFd
1 year ago...